UK markets closed

CureVac N.V. (CVAC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
115.48+1.38 (+1.21%)
As of 11:27AM EDT. Market open.
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
48,900
48,900
17,416
12,871
Cost of revenue
-
-
27,983
17,744
Gross profit
-
-
-10,567
-4,873
Operating expenses
Research development
-
-
43,242
41,722
Selling general and administrative
-
-
43,938
21,500
Total operating expenses
158,700
158,700
88,930
67,951
Operating income or loss
-109,800
-109,800
-99,497
-72,824
Interest expense
-
-
1,460
275
Income before tax
-129,800
-129,800
-100,125
-71,131
Income tax expense
-
-
-252
110
Income from continuing operations
-129,800
-129,800
-99,873
-71,241
Net income
-129,800
-129,800
-99,873
-71,241
Net income available to common shareholders
-129,800
-129,800
-99,873
-71,241
Basic EPS
-
-0.72
-0.57
-0.40
Diluted EPS
-
-0.72
-0.57
-0.40
Basic average shares
-
181,163
175,968
175,968
Diluted average shares
-
181,163
175,968
175,968
EBITDA
-
-109,800
-91,501
-67,075